Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

Management of organ transplant recipients attending a high-throughput skin cancer surgery and surveillance clinic in Queensland.

Papier K, Gordon LG, Khosrotehrani K, Isbel N, Campbell S, Griffin A, Green AC.

Br J Dermatol. 2018 Jul 13. doi: 10.1111/bjd.17001. [Epub ahead of print]

PMID:
30005137
2.

Out-of-pocket medical expenses for Queenslanders with a major cancer.

Gordon LG, Elliott TM, Olsen CM, Pandeya N, Whiteman DC.

Med J Aust. 2018 Jun 18;208(11):497. No abstract available.

PMID:
29902395
3.

Increase in preventive behaviour by organ transplant recipients after sun protection information in a skin cancer surveillance clinic.

Papier K, Gordon LG, Khosrotehrani K, Isbel N, Campbell S, Griffin A, Green AC.

Br J Dermatol. 2018 Jun 8. doi: 10.1111/bjd.16836. [Epub ahead of print]

PMID:
29885042
4.

Sun Protection Among Organ Transplant Recipients After Participation in a Skin Cancer Research Study.

Hartman RI, Green AC, Gordon LG; Skin Tumours and Allograft Recipients (STAR) Study.

JAMA Dermatol. 2018 Jul 1;154(7):842-844. doi: 10.1001/jamadermatol.2018.1164. No abstract available.

PMID:
29874380
5.

Cost-effectiveness of Skin Cancer Referral and Consultation Using Teledermoscopy in Australia.

Snoswell CL, Caffery LJ, Whitty JA, Soyer HP, Gordon LG.

JAMA Dermatol. 2018 Jun 1;154(6):694-700. doi: 10.1001/jamadermatol.2018.0855.

PMID:
29801161
6.

Estimating the healthcare costs of treating prostate cancer in Australia: A Markov modelling analysis.

Gordon LG, Tuffaha HW, James R, Keller AT, Lowe A, Scuffham PA, Gardiner RA.

Urol Oncol. 2018 Mar;36(3):91.e7-91.e15. doi: 10.1016/j.urolonc.2017.10.024. Epub 2017 Nov 21.

PMID:
29169847
7.

Multiplicity of skin cancers in Queensland and their cost burden to government and patients.

Gordon LG, Elliott TM, Olsen CM, Pandeya N, Whiteman DC.

Aust N Z J Public Health. 2018 Feb;42(1):86-91. doi: 10.1111/1753-6405.12738. Epub 2017 Nov 22.

PMID:
29168287
8.

Noninvasive fetal RHD genotyping of RhD negative pregnant women for targeted anti-D therapy in Australia: A cost-effectiveness analysis.

Gordon LG, Hyland CA, Hyett JA, O'Brien H, Millard G, Flower RL, Gardener GJ.

Prenat Diagn. 2017 Dec;37(12):1245-1253. doi: 10.1002/pd.5176.

PMID:
29096422
9.

Erratum to: Estimated Healthcare Costs of Melanoma in Australia Over 3 Years Post-Diagnosis.

Elliott TM, Whiteman DC, Olsen CM, Gordon LG.

Appl Health Econ Health Policy. 2017 Dec;15(6):817-818. doi: 10.1007/s40258-017-0347-5.

PMID:
28900901
10.

Reduced employment and financial hardship among middle-aged individuals with colorectal cancer.

Gordon LG, Beesley VL, Mihala G, Koczwara B, Lynch BM.

Eur J Cancer Care (Engl). 2017 Sep;26(5). doi: 10.1111/ecc.12744. Epub 2017 Aug 3.

PMID:
28771857
11.

Estimated Healthcare Costs of Melanoma in Australia Over 3 Years Post-Diagnosis.

Elliott TM, Whiteman DC, Olsen CM, Gordon LG.

Appl Health Econ Health Policy. 2017 Dec;15(6):805-816. doi: 10.1007/s40258-017-0341-y. Erratum in: Appl Health Econ Health Policy. 2017 Sep 12;:.

PMID:
28756584
12.

Financial Toxicity Among Patients With Cancer-Where to From Here?

Gordon LG, Chan RJ.

Cancer Nurs. 2017 Jul/Aug;40(4):257-258. doi: 10.1097/NCC.0000000000000510. No abstract available.

PMID:
28622195
13.

Cost-Effectiveness Analysis of a Skin Awareness Intervention for Early Detection of Skin Cancer Targeting Men Older Than 50 Years.

Gordon LG, Brynes J, Baade PD, Neale RE, Whiteman DC, Youl PH, Aitken JF, Janda M.

Value Health. 2017 Apr;20(4):593-601. doi: 10.1016/j.jval.2016.12.017. Epub 2017 Feb 15.

14.

Economic evaluation of an exercise-counselling intervention to enhance smoking cessation outcomes: The Fit2Quit trial.

Leung W, Roberts V, Gordon LG, Bullen C, McRobbie H, Prapavessis H, Jiang Y, Maddison R.

Tob Induc Dis. 2017 Mar 29;15:21. doi: 10.1186/s12971-017-0126-y. eCollection 2017.

15.

What does it cost Medicare to diagnose and treat men with localized prostate cancer in the first year?

Mervin MC, Lowe A, Gardiner RA, Smith DP, Aitken J, Chambers SK, Gordon LG.

Asia Pac J Clin Oncol. 2017 Jun;13(3):152-159. doi: 10.1111/ajco.12663. Epub 2017 Mar 16.

PMID:
28303657
16.

Toward More Efficient Surveillance of Barrett's Esophagus: Identification and Exclusion of Patients at Low Risk of Cancer.

Lindblad M, Bright T, Schloithe A, Mayne GC, Chen G, Bull J, Bampton PA, Fraser RJ, Gatenby PA, Gordon LG, Watson DI.

World J Surg. 2017 Apr;41(4):1023-1034. doi: 10.1007/s00268-016-3819-0.

PMID:
27882416
17.

Association between change in employment participation and quality of life in middle-aged colorectal cancer survivors compared with general population controls.

Beesley VL, Vallance JK, Mihala G, Lynch BM, Gordon LG.

Psychooncology. 2017 Sep;26(9):1354-1360. doi: 10.1002/pon.4306. Epub 2016 Dec 15.

PMID:
27862573
18.

A Systematic Review of Financial Toxicity Among Cancer Survivors: We Can't Pay the Co-Pay.

Gordon LG, Merollini KMD, Lowe A, Chan RJ.

Patient. 2017 Jun;10(3):295-309. doi: 10.1007/s40271-016-0204-x. Review.

PMID:
27798816
19.

Cost-effectiveness analysis of multiparametric MRI with increased active surveillance for low-risk prostate cancer in Australia.

Gordon LG, James R, Tuffaha HW, Lowe A, Yaxley J.

J Magn Reson Imaging. 2017 May;45(5):1304-1315. doi: 10.1002/jmri.25504. Epub 2016 Oct 11.

PMID:
27726240
20.

Cost-effectiveness of a pragmatic exercise intervention for women with breast cancer: results from a randomized controlled trial.

Gordon LG, DiSipio T, Battistutta D, Yates P, Bashford J, Pyke C, Eakin E, Hayes SC.

Psychooncology. 2017 May;26(5):649-655. doi: 10.1002/pon.4201. Epub 2016 Aug 2.

PMID:
27338125
21.

Efficient Value of Information Calculation Using a Nonparametric Regression Approach: An Applied Perspective.

Tuffaha HW, Strong M, Gordon LG, Scuffham PA.

Value Health. 2016 Jun;19(4):505-9. doi: 10.1016/j.jval.2016.01.011. Epub 2016 Mar 30. Review.

22.

A comparison of the direct medical costs for individuals with or without basal or squamous cell skin cancer: A study from Australia.

Rowell D, Gordon LG, Olsen CM, Whiteman DC.

SAGE Open Med. 2016 May 11;4:2050312116646030. doi: 10.1177/2050312116646030. eCollection 2016.

23.

Cost-effectiveness Analysis of Nutritional Support for the Prevention of Pressure Ulcers in High-Risk Hospitalized Patients.

Tuffaha HW, Roberts S, Chaboyer W, Gordon LG, Scuffham PA.

Adv Skin Wound Care. 2016 Jun;29(6):261-7. doi: 10.1097/01.ASW.0000482992.87682.4c.

PMID:
27171254
24.

Modelling the healthcare costs of skin cancer in South Africa.

Gordon LG, Elliott TM, Wright CY, Deghaye N, Visser W.

BMC Health Serv Res. 2016 Apr 2;16:113. doi: 10.1186/s12913-016-1364-z.

25.

Cost-effectiveness of dual-energy X-ray absorptiometry plus antiresorptive treatment in Australian women with breast cancer who receive aromatase inhibitors.

Sowa PM, Downes MJ, Gordon LG.

J Bone Miner Metab. 2017 Mar;35(2):199-208. doi: 10.1007/s00774-016-0742-2. Epub 2016 Mar 11.

PMID:
26969395
26.

"Cancer Put My Life on Hold": Work-Related Challenges Among Middle-aged Adults 12 Months After a Diagnosis of Colorectal Cancer.

McGrath C, Mihala G, Beesley VL, Lynch BM, Graves N, Gordon LG.

Cancer Nurs. 2017 Mar/Apr;40(2):160-167. doi: 10.1097/NCC.0000000000000359.

PMID:
26925997
27.

Views from senior Australian cancer researchers on evaluating the impact of their research: results from a brief survey.

Gordon LG, Bartley N.

Health Res Policy Syst. 2016 Jan 12;14:2. doi: 10.1186/s12961-015-0073-0.

28.

Financial toxicity: a potential side effect of prostate cancer treatment among Australian men.

Gordon LG, Walker SM, Mervin MC, Lowe A, Smith DP, Gardiner RA, Chambers SK.

Eur J Cancer Care (Engl). 2017 Jan;26(1). doi: 10.1111/ecc.12392. Epub 2015 Oct 1.

29.

Cost-Effectiveness of Repetitive Transcranial Magnetic Stimulation versus Antidepressant Therapy for Treatment-Resistant Depression.

Nguyen KH, Gordon LG.

Value Health. 2015 Jul;18(5):597-604. doi: 10.1016/j.jval.2015.04.004.

30.

Associations of health behaviours with return to work outcomes after colorectal cancer.

Lynch BM, Mihala G, Beesley VL, Wiseman AJ, Gordon LG.

Support Care Cancer. 2016 Feb;24(2):865-870. doi: 10.1007/s00520-015-2855-x. Epub 2015 Jul 23.

PMID:
26198457
31.

A telephone-delivered multiple health behaviour change intervention for colorectal cancer survivors: making the case for cost-effective healthcare.

Gordon LG, Patrao T, Kularatna S, Hawkes AL.

Eur J Cancer Care (Engl). 2015 Nov;24(6):854-61. doi: 10.1111/ecc.12345. Epub 2015 Jun 29.

PMID:
26121998
32.

Relative cost-effectiveness of home visits and telephone contacts in preventing early childhood caries.

Koh R, Pukallus M, Kularatna S, Gordon LG, Barnett AG, Walsh LJ, Seow WK.

Community Dent Oral Epidemiol. 2015 Dec;43(6):560-8. doi: 10.1111/cdoe.12181. Epub 2015 Jun 25.

PMID:
26110399
33.

A reconstruction of a medical history from administrative data: with an application to the cost of skin cancer.

Rowell D, Gordon LG, Olsen CM, Whiteman DC.

Health Econ Rev. 2015 Feb 11;5:4. doi: 10.1186/s13561-015-0042-x. eCollection 2015.

34.

Cost-utility analysis of negative pressure wound therapy in high-risk cesarean section wounds.

Tuffaha HW, Gillespie BM, Chaboyer W, Gordon LG, Scuffham PA.

J Surg Res. 2015 May 15;195(2):612-22. doi: 10.1016/j.jss.2015.02.008. Epub 2015 Feb 13.

PMID:
25796106
35.

Cost-effectiveness and value of information analysis of nutritional support for preventing pressure ulcers in high-risk patients: implement now, research later.

Tuffaha HW, Roberts S, Chaboyer W, Gordon LG, Scuffham PA.

Appl Health Econ Health Policy. 2015 Apr;13(2):167-79. doi: 10.1007/s40258-015-0152-y.

PMID:
25650349
36.

Australian clinical practice guidelines for the diagnosis and management of Barrett's esophagus and early esophageal adenocarcinoma.

Whiteman DC, Appleyard M, Bahin FF, Bobryshev YV, Bourke MJ, Brown I, Chung A, Clouston A, Dickins E, Emery J, Eslick GD, Gordon LG, Grimpen F, Hebbard G, Holliday L, Hourigan LF, Kendall BJ, Lee EY, Levert-Mignon A, Lord RV, Lord SJ, Maule D, Moss A, Norton I, Olver I, Pavey D, Raftopoulos S, Rajendra S, Schoeman M, Singh R, Sitas F, Smithers BM, Taylor AC, Thomas ML, Thomson I, To H, von Dincklage J, Vuletich C, Watson DI, Yusoff IF.

J Gastroenterol Hepatol. 2015 May;30(5):804-20. doi: 10.1111/jgh.12913. Review.

PMID:
25612140
37.

Adverse breast cancer treatment effects: the economic case for making rehabilitative programs standard of care.

Schmitz KH, DiSipio T, Gordon LG, Hayes SC.

Support Care Cancer. 2015 Jun;23(6):1807-17. doi: 10.1007/s00520-014-2539-y. Epub 2014 Dec 5.

PMID:
25471182
38.

Cost-Effectiveness and Value of Information Analyses of Nutritional Support in Preventing Pressure Ulcers in High Risk Hospitalised Patients.

Tuffaha HW, Shelley R, Chaboyer W, Gordon LG, Scuffham PA.

Value Health. 2014 Nov;17(7):A612-3. doi: 10.1016/j.jval.2014.08.2150. Epub 2014 Oct 26. No abstract available.

39.

The return to work experiences of middle-aged Australian workers diagnosed with colorectal cancer: a matched cohort study.

Gordon LG, Beesley VL, Lynch BM, Mihala G, McGrath C, Graves N, Webb PM.

BMC Public Health. 2014 Sep 17;14:963. doi: 10.1186/1471-2458-14-963.

40.

Health system costs of skin cancer and cost-effectiveness of skin cancer prevention and screening: a systematic review.

Gordon LG, Rowell D.

Eur J Cancer Prev. 2015 Mar;24(2):141-9. doi: 10.1097/CEJ.0000000000000056. Review.

PMID:
25089375
41.

Value of information analysis optimizing future trial design from a pilot study on catheter securement devices.

Tuffaha HW, Reynolds H, Gordon LG, Rickard CM, Scuffham PA.

Clin Trials. 2014 Dec;11(6):648-56. doi: 10.1177/1740774514545634. Epub 2014 Jul 31.

PMID:
25084784
42.

Response.

Gordon LG, Mayne GC, Bright T, Whiteman DC, Watson DI.

Gastrointest Endosc. 2014 Jul;80(1):191. doi: 10.1016/j.gie.2014.02.020. No abstract available.

PMID:
24950651
43.

The ENHANCES study--Enhancing Head and Neck Cancer patients' Experiences of Survivorship: study protocol for a randomized controlled trial.

Turner J, Yates P, Kenny L, Gordon LG, Burmeister B, Thomson D, Hughes B, McCarthy AL, Perry C, Chan RJ, Fraser A, Skerman H, Batstone M, Carswell K.

Trials. 2014 May 28;15:191. doi: 10.1186/1745-6215-15-191.

44.

Value of information analysis in healthcare: a review of principles and applications.

Tuffaha HW, Gordon LG, Scuffham PA.

J Med Econ. 2014 Jun;17(6):377-83. doi: 10.3111/13696998.2014.907170. Epub 2014 Mar 27. Review.

PMID:
24650041
45.

A cost-effectiveness analysis of a telephone-linked care intervention for individuals with Type 2 diabetes.

Gordon LG, Bird D, Oldenburg B, Friedman RH, Russell AW, Scuffham PA.

Diabetes Res Clin Pract. 2014 Apr;104(1):103-11. doi: 10.1016/j.diabres.2013.12.032. Epub 2014 Jan 14.

PMID:
24503043
46.

Uptake of skin self-examination and clinical examination behavior by outdoor workers.

Walton AE, Janda M, Youl PH, Baade P, Aitken JF, Whiteman DC, Gordon LG, Neale RE.

Arch Environ Occup Health. 2014;69(4):214-22. doi: 10.1080/19338244.2013.771247.

PMID:
24499249
47.

Cost savings for elective laparoscopic resection compared with open resection for colorectal cancer in a region of high uptake.

Thompson BS, Coory MD, Gordon LG, Lumley JW.

Surg Endosc. 2014 May;28(5):1515-21. doi: 10.1007/s00464-013-3345-1. Epub 2013 Dec 14.

PMID:
24337191
48.

The cost-effectiveness and consumer acceptability of taxation strategies to reduce rates of overweight and obesity among children in Australia: study protocol.

Comans TA, Whitty JA, Hills AP, Kendall E, Turkstra E, Gordon LG, Byrnes JM, Scuffham PA.

BMC Public Health. 2013 Dec 14;13:1182. doi: 10.1186/1471-2458-13-1182.

49.

Value of information analysis in oncology: the value of evidence and evidence of value.

Tuffaha HW, Gordon LG, Scuffham PA.

J Oncol Pract. 2014 Mar;10(2):e55-62. doi: 10.1200/JOP.2013.001108. Epub 2013 Nov 5. Review.

PMID:
24194511
50.

Cost-effectiveness of Barrett's oesophagus screening and surveillance.

Gordon LG, Mayne GC.

Best Pract Res Clin Gastroenterol. 2013 Dec;27(6):893-903. doi: 10.1016/j.bpg.2013.08.019. Epub 2013 Sep 27. Review.

PMID:
24182609

Supplemental Content

Loading ...
Support Center